Clinical Trials Sponsored by International Group of Endovascular Oncology

Total 384 results

International Group of Endovascular Oncology

Unknown

MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric Cancer (MICADO)

Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma

Italy
International Group of Endovascular Oncology

Unknown

Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCC (LIFDOX)

Hepatocellular Carcinoma

Italy
International Group of Endovascular Oncology

Unknown

Isolated Limb Perfusion of Melphalan for Melanoma and Sarcoma Treatment (ILI)

Metastatic Melanoma

Italy
International Group of Endovascular Oncology

Unknown

Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular Carcinoma (DEBDOX)

Liver Cell Carcinoma Non-resectable

Italy
International Group of Endovascular Oncology

Unknown

Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric Cancer (MATURE)

Metastatic Gastric Cancer

Italy
International Group of Endovascular Oncology

Completed

Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab (TACETUX)

Colon Cancer Liver Metastasis

Italy
International Group of Endovascular Oncology

Unknown

International Registry on Cholangiocarcinoma Treatment (CHOLANGIO)

Cholangiocarcinoma

Italy
Giammaria Fiorentini

Unknown

TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer (EMBOBEVA)

Liver Metastasis Colon Cancer

Italy
International Group of Endovascular Oncology
Azienda Sanitaria Ospedaliera

Unknown

Observational Study With Metronomic Oral Vinorelbine in Elderly Patients With Locally Advanced / Metastatic Non-small-cell Lung Cancer (NSCLC) (VINORELBINA)

Locally Advanced/ Metastatic NSCLC

Italy
University Hospital Muenster
International Lymphoma Radiation Oncology Group (ILROG)

Recruiting

ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma

Follicular Lymphoma (Gastric or Duodenal) | Marginal Zone Lymphoma (Gastric or Duodenal)

Germany
Dutch Childhood Oncology Group
St. Jude Children's Research Hospital; International BFM Study Group

Completed

Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
Seagen Inc.
Gynecologic Oncology Group; European Network of Gynaecological Oncological... and other collaborators

Completed

A Trial of Tisotumab Vedotin in Cervical Cancer

Cervical Cancer

Belgium, Spain, United States, Denmark, Italy, Germany, Czechia, Sweden
Hellenic Cooperative Oncology Group
Hellenic Society of Medical Oncology

Active, not recruiting

Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer

Metastatic Breast Cancer

Greece
European Organisation for Research and Treatment...
Hellenic Oncology Research Group; Latin American Cooperative Oncology Group; Hellenic... and other collaborators

Active, not recruiting

Male Breast Cancer: Understanding the Biology for Improved Patient Care

Breast Cancer

United States, Ireland, United Kingdom, Belgium, Switzerland, Spain, Poland, Greece, Portugal, Egypt, Brazil, Mexico, Netherlands, Peru, Serbia, Sweden
Netherlands Working Group on Immunotherapy of Oncology

Completed

Rotating Pazopanib and Everolimus to Avoid Resistance (ROPETAR)

Clear Cell Renal Carcinoma

Netherlands
Hellenic Cooperative Oncology Group
University of Ioannina

Completed

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

Breast Cancer | Prostate Cancer | Non Small Cell Lung Cancer

Greece
University of Bern
Swiss Pediatric Oncology Group

Recruiting

Swiss Childhood Cancer Survivor Study (SCCSS)

Childhood Cancer

Switzerland
University of Athens
Hellenic Cooperative Oncology Group

Completed

Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)

Amyloidosis

Greece
European Organisation for Research and Treatment...
Eastern Cooperative Oncology Group; Southwest Oncology Group; Scandinavian Sarcoma...

Completed

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Sarcoma | Kidney Cancer | Ovarian Cancer | Metastatic Cancer | Endometrial Cancer | Pheochromocytoma

Sweden
ETOP IBCSG Partners Foundation
Alliance for Clinical Trials in Oncology; Canadian Cancer Trials Group; Breast...

Active, not recruiting

Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer (POSITIVE)

Early Breast Cancer

Korea, Republic of, United States, France, Canada, Spain, Lebanon, Belgium, Switzerland, Israel, Ireland, Japan, Italy, Denmark, Austria, Australia, Greece, Hungary, Netherlands, Norway, Portugal, Serbia, Slovenia
Rabin Medical Center
International BFM Study Group; Israeli Society for Pediatric Hematology-Oncology

Recruiting

Lymphoproliferative Disorders After Diagnosis of Childhood Acute Lymphoblastic Leukemia/Lymphoma

Childhood Leukemia and Lymphoma

Israel
ImmunoGen, Inc.
Gynecologic Oncology Group; European Network of Gynaecological Oncological...

Active, not recruiting

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (MIRASOL)

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer

United States, Canada, Germany, China, France, Korea, Republic of, Belgium, United Kingdom, Serbia, Spain, Australia, Israel, Italy, Taiwan, Czechia, Bulgaria, Netherlands, Portugal, Poland, Russian Federation, Ukraine
Ontario Clinical Oncology Group (OCOG)
Canadian Institutes of Health Research (CIHR); Trans Tasman Radiation Oncology...

Completed

PROFIT - Prostate Fractionated Irradiation Trial

Prostate Cancer

Canada, Australia, France
Federation of Italian Cooperative Oncology Groups

Recruiting

Prospective and Multicenter Italian Registry of Locally Advanced-Metastatic Urothelial Carcinoma

Carcinoma, Urothelial

Italy
European Institute of Oncology
Janssen-Cilag International NV

Active, not recruiting

CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER

Breast Cancer

Italy
Rabin Medical Center
International BFM Study Group; Israeli Society for Pediatric Hematology-Oncology

Recruiting

Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia

Lymphoma | Leukemia | Ataxia Telangiectasia

Israel
AGO Study Group
GERCOR - Multidisciplinary Oncology Cooperative Group; Nordic Society of Gynaecological...

Completed

Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer (AGO-OVAR9)

Ovarian Cancer | Fallopian Tube Cancer

Norway, Germany, France, Denmark
University of Kansas Medical Center
Southwest Oncology Group

Unknown

Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation (Auto-HBO)

Multiple Myeloma | Non-Hodgkin's Lymphoma | Hodgkin's Disease

United States
Southwest Oncology Group
University of Michigan; Hope Foundation

Completed

S1119 Peruvian H. Pylori Water Contamination Study

Helicobacter Pylori Infection

Peru
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer

Bladder Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer

Breast Cancer

Greece
University of British Columbia
Canadian Urologic Oncology Group

Completed

Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder Cancer

Transitional Cell Carcinoma | Bladder Cancer

Canada
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC

Colorectal Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC

Non-small-cell Lung Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients

Breast Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas

Ovarian Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer

Metastatic Breast Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Greece
Nordic Society of Gynaecological Oncology - Clinical...
ARCAGY/ GINECO GROUP; Belgian Gynaecological Oncology Group; North Eastern German...

Completed

Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer

Endometrial Cancer

France, Belgium, Germany, Norway, Finland, Sweden, Denmark
Nordic Society of Gynaecological Oncology - Clinical...
Hellenic Cooperative Oncology Group; European Network of Gynaecological Oncological... and other collaborators

Recruiting

Olaparib, Durvalumab and UV1 in Relapsed Ovarian Cancer (DOVACC)

Ovarian Cancer

Denmark
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; NCIC Clinical... and other collaborators

Terminated

S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer

Breast Cancer

Canada
University of Sydney
Trans Tasman Radiation Oncology Group

Unknown

Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (SPARK)

Prostate Cancer

Australia
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer

Breast Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma

Ovarian Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer

Non-small-cell Lung Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer

Breast Cancer

Greece

Clinical Trials Sponsored by International Group of Endovascular Oncology

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations